Circular RNA profiling identified as a biomarker for predicting the efficacy of Gefitinib therapy or non-small cell lung cancer | |
Liu, Yu-Tao; Han, Xiao-Hong; Xing, Pu-Yuan; Hu, King-Sheng; Hao, Xue-Zhi; Wang, Yan; Li, Jun-Ling; Zhang, Zhi-Shang; Yang, Zhi-Hao; Shi, Yuan-Kai | |
2019 | |
卷号 | 11期号:5页码:1779-+ |
关键词 | Non-small cell lung cancer (NSCLC) circular RNA (circRNA) epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) predictive biomarker |
ISSN号 | 2072-1439 |
DOI | 10.21037/jtd.2019.05.22 |
URL标识 | 查看原文 |
收录类别 | SCIE ; PUBMED |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6340119 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Liu, Yu-Tao,Han, Xiao-Hong,Xing, Pu-Yuan,et al. Circular RNA profiling identified as a biomarker for predicting the efficacy of Gefitinib therapy or non-small cell lung cancer[J],2019,11(5):1779-+. |
APA | Liu, Yu-Tao.,Han, Xiao-Hong.,Xing, Pu-Yuan.,Hu, King-Sheng.,Hao, Xue-Zhi.,...&Shi, Yuan-Kai.(2019).Circular RNA profiling identified as a biomarker for predicting the efficacy of Gefitinib therapy or non-small cell lung cancer.,11(5),1779-+. |
MLA | Liu, Yu-Tao,et al."Circular RNA profiling identified as a biomarker for predicting the efficacy of Gefitinib therapy or non-small cell lung cancer".11.5(2019):1779-+. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论